Consumer Information for: JAMP-TENOFOVIR
Consumer Information
Information about the product including what the product is used for, dosage, warnings, proper use and side effects. This summary will not tell you everything about the product. Contact your healthcare professional if you have any questions about the product.
What the medication is used for
- JAMP-TENOFOVIR is a type of medicine called a nucleotide analog reverse transcriptase inhibitor (NRTI).
- Use in the Treatment of HIV-Infection:
JAMP-TENOFOVIR is a treatment for Human
Immunodeficiency Virus (HIV) infection in adults
and adolescents age 12 years and older and
weighing at least 35 kg (77 lb). JAMP-TENOFOVIR is always used in combination with
other anti-HIV medicines to treat people with HIV
infection.
HIV infection destroys CD4+ (T) cells, which are important to the immune system. After a large number of T cells are destroyed, acquired immune deficiency syndrome (AIDS) develops. - Use in the Treatment of Chronic Hepatitis B: JAMP-TENOFOVIR is also used to treat chronic hepatitis B (an infection with hepatic B virus [HBV]) in adults age 18 years and older.
- If you have both HIV and HBV infection and are taking JAMP-TENOFOVIR, your healthcare professional should be prescribing JAMP-TENOFOVIR in combination with other anti-HIV medicines (See: Proper Use of This Medication).
What it does
Treatment of HIV infection:
- In patients with HIV infection, JAMP-TENOFOVIR helps to block HIV reverse transcriptase (enzyme) that is needed for HIV to multiply. JAMP-TENOFOVIR lowers the amount of HIV in the blood (called viral load).
- JAMP-TENOFOVIR does not cure HIV infection or AIDS. The long- term effects of JAMP-TENOFOVIR are not known at this time. People taking JAMP-TENOFOVIR may still get opportunistic infections or other conditions that happen with HIV infection. Opportunistic infections are infections that develop because the immune system is weak.
Treatment of Chronic Hepatitis B:
- In patients with HBV infection, JAMP-TENOFOVIR works by interfering with the normal working of enzymes (HBV DNA polymerase) that are essential for the HBV virus to reproduce itself. JAMP-TENOFOVIR may help lower the amount of hepatitis B virus in your body by lowering the ability of the virus to multiply and infect newliver cells.
- We do not know how long JAMP-TENOFOVIR may help your hepatitis. Sometimes viruses change in your body and medicines no longer work. This is called drug resistance.
JAMP-TENOFOVIR does not reduce the risk of passing HIV or HBV to others through sexual contact or blood contamination. Continue to practice safe sex and do not use or share dirty needles.
When it should not be used
- Do not take JAMP-TENOFOVIR if you are allergic to JAMP-TENOFOVIR or any of its ingredients (See: What the important nonmedicinal ingredients are).
What the medicinal ingredient is
tenofovir disoproxil fumarate (TDF)
What the non-medicinal ingredients are
croscarmellose sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and pregelatinized starch and the film coating contains FD&C blue #2 aluminum lake, Hydroxypropyl methylcellulose, lactose monohydrate, titanium dioxide, and triacetin.
What dosage form it comes in
JAMP-TENOFOVIR is available as tablets. Each tablet contains 300 mg of tenofovir disoproxil fumarate, which is equivalent to 245 mg of tenofovir disoproxil. The tablets are oval-shaped, blue, film-coated, and debossed with “CL77” on one side and plain on the other side.
Warnings and precautions
Serious Warnings and Precautions
- The most serious possible side effect is harm to the kidneys, including damage to kidney cells, kidney tissue inflammation and kidney failure. Your healthcare professional may monitor your kidney function before beginning and while receiving JAMP-TENOFOVIR. Some patients treated with TDF (a component of JAMP-TENOFOVIR) have had kidney problems. Your healthcare professional may need to perform additional blood tests if you have had kidney problems in the past or need to take another drug that can cause kidney problems.
- If you have Hepatitis B Virus infection or if you have HIV and HBV infection together, “flare-ups” of Hepatitis B Virus infection, in which the disease suddenly returns in a worse way than before, can occur if you stop taking JAMP-TENOFOVIR. Do not stop taking JAMP-TENOFOVIR without your healthcare professional’s advice. If you stop taking JAMP-TENOFOVIR, tell your healthcare professional immediately about any new, unusual or worsening symptoms that you notice after stopping treatment. After you stop taking JAMP-TENOFOVIR, your healthcare professional will still need to check your health and take blood tests to check your liver for several months.
- The class of medicines to which JAMP-TENOFOVIR belongs (NRTIs) can cause a condition called lactic acidosis (build-up of acid in the blood). The symptoms that may be signs of lactic acidosis include: feeling very weak, tired or uncomfortable; unusual or unexpected stomach discomfort, feeling cold, feeling dizzy or lightheaded; suddenly developing a slow or irregular heartbeat. This rare but serious side effect has occasionally been fatal.
- Severe liver problems can happen in people
who take JAMP-TENOFOVIR or similar
medicines. You may develop an enlarged liver
(hepatomegaly) or a fatty liver (steatosis). Nonspecific symptoms such as yellowing of the
skin and eyes, nausea, vomiting, and stomach
pain might indicate the development of liver
problems.
Lactic acidosis or severe liver problems occur more often in women, particularly if they are very overweight. You should consult your healthcare professional immediately if such symptoms occur while you are receiving JAMP-TENOFOVIR. If you notice these symptoms, stop taking JAMP-TENOFOVIR and consult a healthcare professional immediately. - TDF caused harm to the bones of animals. TDF reduced bone density in humans. If you notice bone pain, suffer a bone fracture, or other bone problem, consult your healthcare professional. If you have bone problems, you may wish to discuss calcium and/or vitamin D supplements with your healthcare professionals.
- Do not take JAMP-TENOFOVIR if you are already taking ATRIPLA® , COMPLERA® , DESCOVY® , GENVOYA® , ODEFSEY™, STRIBILD® , TRUVADA® , or VEMLIDY™ because these medicines contain the same or similar active ingredients.
- Do not take JAMP-TENOFOVIR if you have not already discontinued treatment with HEPSERA .
BEFORE you use JAMP-TENOFOVIR talk to your healthcare professional if:
- You are pregnant or planning to become pregnant: Pregnant mothers should not take JAMP-TENOFOVIR unless specifically directed by the healthcare professional. If you take JAMP-TENOFOVIR while you are pregnant, talk to your healthcare professional about how you can be included in the Antiviral PregnancyRegistry.
- You are breastfeeding or planning to breastfeed: Do not breastfeed if you are taking JAMP-TENOFOVIR. Tenofovir passes to your baby in your breast milk. You should not breastfeed because of the risk of passing HIV or HBV to your baby. Talk to your healthcare professional about the best way to feed your baby.
- You have other medical conditions: Let your healthcare professional know if you have other medical conditions, especially hepatitis (inflammation of the liver), pancreatitis (inflammation of the pancreas), and bone and kidney problems.
- You have HIV Infection.
- You are taking other medicines: Some medicines can interact when taken together, including prescription and non-prescription medicines and dietary supplements.
Other Special Warnings:
Your blood sugar levels (glucose) or levels of fats
(lipids) in your blood may increase with HIV treatment.
Your doctor may order blood testsfor you.
Interactions with this medication
- Drugs that contain didanosine (Videx , Videx EC ). TDF (JAMP-TENOFOVIR) may increase the amount of Videx in your blood. You may need to be followed more carefully if you are taking JAMP-TENOFOVIR and Videx together. Also, the dose of didanosine may need to be reduced.
- Reyataz® (atazanavir sulfate), Kaletra® (lopinavir/ritonavir), Prezista® (darunavir), HARVONI® (ledipasvir/sofosbuvir), EPCLUSA® (sofosbuvir/velpatasvir), or VOSEVI™ (sofosbuvir/velpatasvir/ voxilaprevir) may increase the amount of TDF (JAMP- TENOFOVIR) in your blood, which could result in more side effects. You may need to be followed more carefully if you are taking JAMP-TENOFOVIR together with Reyataz, Kaletra, Prezista, HARVONI, EPCLUSA, or VOSEVI. JAMP-TENOFOVIR may decrease the amount of Reyataz in your blood. If you are taking JAMP-TENOFOVIR and Reyataz, together, you should also be taking Norvir® (ritonavir).
Proper use of this medication
Stay under a healthcare professional’s care when taking
JAMP-TENOFOVIR. Do not change your treatment or
stop treatment without first talking with your healthcare
professional.
Carefully follow the directions and dosing schedule
prescribed by your healthcare professional.
When your JAMP-TENOFOVIR supply starts to run
low, see your healthcare professional for a refill. This is
very important because the amount of virus in your
blood may increase if the medicine is stopped for even a
short time. The virus may develop resistance to JAMP-TENOFOVIR and become harder to treat.
If you are taking JAMP-TENOFOVIR to treat your HIV
or if you have HIV and HBV coinfection and are taking
JAMP-TENOFOVIR, always take JAMP-TENOFOVIR
in combination with other anti-HIV medicines.
JAMP-TENOFOVIR and other products like JAMP-TENOFOVIR may be less likely to work in the future if
you are not taking JAMP-TENOFOVIR with other antiHIV medicines because you may develop resistance to
those medicines.
If you have HBV only (without HIV), JAMP-TENOFOVIR can be prescribed as a single drug
treatment for HBV.
Talk to your healthcare professional about taking an
HIV test before you start treatment with JAMP-TENOFOVIR for chronic hepatitis B.
Only take medicine that has been prescribed specifically
for you. Do not give JAMP-TENOFOVIR to others or
take medicine prescribed for someone else.
Usual Adult Dose:
- The usual dose of JAMP-TENOFOVIR is one 300 mg tablet orally (by mouth) once a day.
- JAMP-TENOFOVIR may be taken with or without a meal.
Usual Adolescent (12 Years of Age and Older) Dose for HIV Infection:
- Body weight ≥35 kg (≥77 lb): Take one 300 mg JAMP-TENOFOVIR tablet once daily orally.
- JAMP-TENOFOVIR may be taken with or without a meal.
Overdose
Missed Dose
- If you miss a dose of JAMP-TENOFOVIR, take it as soon as possible and then take your next scheduled dose at its regular time.
- Do not double the next dose.
Side effects and what to do about them
The most common side effects of JAMP-TENOFOVIR are:
- Diarrhea
- Nausea
- Vomiting
- Dizziness
Other side effectsinclude:
- Flatulence (intestinal gas)
- Allergic reaction, including angioedema (swelling of the blood vessels) with symptoms such as skin rash, redness, swelling of the hands, legs, feet, face, lips, tongue or throat, with difficulty in breathing
- Stomach pain
- Weakness
- Inflammation of the pancreas
- Shortness of breath
- Headache
- Rash
Changes in your immune system (Immune
Reconstitution Inflammatory Syndrome) can happen
when you start taking HIV medicines. Your immune
system may get stronger and begin to fight infections
that have been hidden in your body for a long time, or
you could develop an autoimmune disease in which your
immune system reacts against your own body [e.g.
Grave's disease (which affects the thyroid gland),
Guillain-Barré syndrome (which affects the nervous
system) or polymyositis (which affects the muscles)] and
it may develop at any time, sometimes months later after
the start of HIV therapy.
Sometimes symptoms can be severe, so if you develop
high temperature (fever), joint or muscle pain, redness,
rash, swelling or fatigue, or any new symptoms, contact
your healthcare professional right away.
Symptom / effect | Talk with your doctor, nurse, or pharmacist only if severe | Talk with your doctor, nurse, or pharmacist in all cases | Stop taking drug and call your healthcare professional |
---|---|---|---|
Rare | |||
Effect: Kidney problems
Symptoms
|
✔ | ||
Effect: Lactic acidosis
Symptoms
|
✔ | ||
Very Rare | |||
Effect: Hepatotoxicity
(severe liver problems)
with hepatomegaly (liver
enlargement) and
steatosis (fat in the liver)
Symptoms
|
✔ | ||
Effect: Flare-ups of
hepatitis B virus infection
following drug
discontinuation
Symptoms
|
✔ |
Lactic acidosis is a medical emergency and must be
treated in the hospital. You may be more likely to get
lactic acidosis or serious liver problems if you are very
overweight (obese) or have been taking nucleoside
analog medicines, like JAMP-TENOFOVIR, for a long
time.
Muscle pain, muscle weakness, bone pain and softening
of the bone (infrequently contributing to fractures) have
also been reported.
This is not a complete list of side effects. For any
unexpected side effects while taking JAMP-TENOFOVIR, contact your healthcare professional.
How to store
- Keep JAMP-TENOFOVIR and all other medications out of reach and sight of children.
- JAMP-TENOFOVIR should at controlled room temperature 15°C –30°C, protect from moisture. It should remain stable until the expiration date printed on the label.
- Do not keep medicine that is out of date or that you no longer need. If you throw any medicines away, make sure that children will not find them.
Reporting side effects
You can report any suspected adverse reactions associated with the use of health products to the Canada Vigilance Program by one of the following three ways:
- Report online at www.healthcanada.gc.ca/medeffect
- Call toll-free at 1-866-234-2345
- Complete a Canada Vigilance Reporting Form and:
- Fax toll-free to 1-866-678-6789, or
- Mail to:
Canada Vigilance Program
Health Canada
Postal Locator 0701E
Ottawa ON K1A 0K9
Postage paid labels, Canada Vigilance Reporting Form and the adverse reaction reporting guidelines are available on the MedEffectTM Canada Web site at www.healthcanada.gc.ca/medeffect.
NOTE: Should you require information related to the management of side effects, contact your health professional. The Canada Vigilance Program does not provide medical advice.
More information
This document plus the full Product Monograph,
prepared for healthcare professionals, can be found by
contacting the sponsor, JAMP Pharma Corporation, at
1-866-399-9091
This leaflet was prepared by JAMP Pharma Corporation
1310 rue Nobel, Boucherville, Québec, J4B 5H3
Last revised: October 4, 2018
Related Drug Products
Product name | DIN | Company name | Active ingredient(s) & strength |
---|---|---|---|
PMS-CYTARABINE | 02406772 | PHARMASCIENCE INC | CYTARABINE 100 MG / ML |
PMS-CYTARABINE | 02406764 | PHARMASCIENCE INC | CYTARABINE 20 MG / ML |